Form D · Biotechnology

Iantrek, Inc.

White Plains, NY · CIK 0001829982

Offering snapshot reported Aug 21, 2025 · SEC filing

Reported sold
$34.7M
Offering amount: $42M
Investors reported
21
Form D · investor count
Minimum accepted
Not reported
Reported outside-investor minimum
First sale
Aug 19, 2025
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Aug 21, 2025Initial$34,748,596No comparison21SEC filing
Feb 26, 2025Initial$2,780,366No comparison4SEC filing
Aug 17, 2022Initial$15,410,669No comparison25SEC filing
Oct 26, 2020Initial$5,223,426No comparison29SEC filing

Offering details

Securities
Not reported
Exemptions
Not reported
Duration over one year
Not reported
Business combination
Not reported
Sales commissions
$0
Finders' fees
$0
Form D file number
021-555477

Source: Form D, filed Aug 21, 2025. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Stephen Bloch Director
Andrew Corley Director
Michael Haydin Executive
Michael George Haydin, Iv Executive
Tsontcho Ianchulev Director, Executive
Marc Andre Marcotte Director
James Mazzo Director
Todd Sone Director
Adam Szaronos Director, Executive
Casey Tansey Director
Farrell Tyson Director
Jeffrey K. Weinhuff Director
Jeffry K. Weinhuff Director
Robert Weinreb Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
151 East Post Road Suite 111
White Plains, NY, 10601